Loading stock data…
STE
$224.59-1.55 (-0.69%)
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
STERIS plc in the Healthcare sector is trading at $224.59. Wall Street consensus targets $263.12 (8 analysts), implying a +17.2% move over the next 12 months. The stock is currently 17% below its 52-week high of $269.44, remaining 3.0% below its 200-day moving average. On fundamentals, Piotroski 9/9 indicates strong financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +17.2% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.49B↓ | $1.59B↑ | $1.50B↑ | $1.46B↑ | $1.39B |
| Gross Profit | $684.20M↓ | $697.10M↑ | $655.50M↑ | $645.90M↑ | $628.00M |
| Operating Income | $285.90M↓ | $316.50M↑ | $273.70M↑ | $268.00M↑ | $247.80M |
| Net Income | $200.10M↓ | $220.20M↑ | $192.80M↑ | $191.90M↑ | $177.40M |
Peer Comparison
JNJUNHPFE
Fundamentals
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chem...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.56%
ROE
Average efficiency. Growth may require heavy reinvestment.
11.17%
Volume
Today's trading volume
468,166
Recent News
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
STERIS (STE) Stock Looks Reasonable On Earnings With Cash Flow Slightly Stretched
STERIS stock has delivered a positive 11.2% total return over the past five years, yet current checks suggest the shares now trade close to a fair level rather than offering an obvious discount. The intrinsic value estimate from a Discounted Cash Flow (DCF) framework is slightly below the recent market price, and the broader valuation tools also lean toward STERIS being on the expensive side. Over five years, STERIS has returned 11.2%, which points to modest long term gains rather than a...
STERIS (STE) Could Be 12% Below Fair Value As Conference Focus Returns
Conference appearance puts STERIS (STE) in the spotlight STERIS (STE) is drawing investor attention after confirming it will participate in the Morgan Stanley Healthcare Conference in New York on September 15, 2026, with CEO Dan Carestio scheduled to present. STERIS shares trade at US$229.65 after a small pullback in the past week, while the 90 day share price return of 9.26% points to building momentum that contrasts with a year to date share price decline of 8.15% and a 1 year total...
STERIS Stock Outlook: Is Wall Street Bullish or Bearish?
STERIS has lagged behind the broader market over the past year, and analysts remain somewhat bullish about the stock’s prospects.
Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?
STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.